Alfasigma to acquire Galapagos’ Jyseleca business

Alfasigma to acquire Galapagos’ Jyseleca business

Source: 
Pharmaceutical Business Review
snippet: 


Alfasigma has entered into an agreement to take over the Jyseleca (filgotinib) business of Galapagos.